Clinical Trials in Philadelphia

Showing 9361-9380 of 15,860 trials

The National Oncologic PET Registry

NCT00868582

The Centers for Medicare \& Medicaid Services (CMS), as the Federal agency that administers the Medicare program, only pays for positron emission tomography (PET) scans in patients with cancer for certain reasons and for certain types of cancer. This study was developed to help CMS determine if they should pay for PET scans for additional reasons and additional types of cancer. In order to collect the information needed to decide which other types of cancer should be covered by Medicare, CMS will provide payment for the otherwise non-covered PET scans of patients who are properly registered with the National Oncologic PET Registry (NOPR). This information will then be analyzed to determine the effect PET scans had on the way physicians planned to treat their patients.

Cancer

American College of Radiology Imaging Network333,000 participantsStarted May 2006

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase

NCT02263079

This randomized, controlled, parallel group, open-label multicenter study will evaluate the efficacy and safety of a combination of pegylated interferon alfa-2A (Pegasys) plus lamivudine or entecavir compared with an untreated control group in participants with HBeAg positive CHB in the immune tolerant phase. NOTE: STUDY RECRUITMENT HAS BEEN TERMINATED

Pediatric Immuno-Tolerant Chronic Hepatitis B

Hoffmann-La Roche62 participantsStarted Jun 2014

Kansas City, Missouri, United States • New York, New York, United States • Philadelphia, Pennsylvania, United States +22 more locations

The National Oncologic PET Registry

A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase

Find Trials by Condition in Philadelphia

Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor

Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

Evaluation of Splinting in Tetraplegia

Safety and Efficacy Study of Spinal Tethering

Ostomy Telehealth For Cancer Survivors

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).

Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A

Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain

Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis

Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)

Study of Endorectal Cooling During RARP to Minimize Trauma and Promote Earlier Return to Continence

Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration